.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Fish and Richardson
Colorcon
Daiichi Sankyo
US Department of Justice
Teva
Citi
Chinese Patent Office
Merck
McKinsey

Generated: September 24, 2017

DrugPatentWatch Database Preview

Terbinafine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for terbinafine hydrochloride and what is the scope of terbinafine hydrochloride freedom to operate?

Terbinafine hydrochloride
is the generic ingredient in three branded drugs marketed by Taro, Breckenridge Pharm, Harris Pharm, Roxane, Novartis, Wockhardt, Invagen Pharms, Mylan, Cipla Ltd, Glaxosmithkline Cons, Glenmark Generics, Orchid Hlthcare, Gedeon Richter Usa, Teva, Glaxosmithkline, Dr Reddys Labs Inc, Aurobindo Pharma, and Apotex, and is included in twenty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-five drug master file entries for terbinafine hydrochloride. Fifty-four suppliers are listed for this compound. There are four tentative approvals for this compound.

Summary for Generic Name: terbinafine hydrochloride

Tradenames:3
Patents:0
Applicants:18
NDAs:22
Drug Master File Entries: see list25
Suppliers / Packagers: see list54
Bulk Api Vendors: see list66
Clinical Trials: see list2,296
Patent Applications: see list1,226
Therapeutic Class:Antifungals
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:terbinafine hydrochloride at DailyMed

Pharmacology for Ingredient: terbinafine hydrochloride

Ingredient-typeAllylamine
Drug ClassAllylamine Antifungal

Tentative approvals for TERBINAFINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 250MG BASETABLET; ORAL
► Subscribe► SubscribeEQ 250MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 250MG BASETABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cipla Ltd
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL077137-001Jul 2, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Invagen Pharms
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL077533-001Jul 2, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Teva
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL076377-001Jul 2, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Orchid Hlthcare
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL078163-001Jul 2, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Breckenridge Pharm
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL077714-001Jun 4, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Roxane
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL077223-001Jul 2, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline Cons
LAMISIL
terbinafine hydrochloride
SOLUTION;TOPICAL020749-001Oct 17, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL077195-001Jul 2, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Harris Pharm
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL077919-001Jul 2, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
Apotex
TERBINAFINE HYDROCHLORIDE
terbinafine hydrochloride
TABLET;ORAL078199-001Jul 2, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: terbinafine hydrochloride

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Citi
Healthtrust
Moodys
Novartis
US Army
Julphar
Johnson and Johnson
Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot